Wednesday July 3, 2019 Dr. Michael Potente Angiogenesis & Metabolism Laboratory Max Planck Institute for Heart and Lung ResearchBad Nauheim, Germany “Metabolic regulation of endothelial growth state”
READ MOREMonday, June 24, 2019 Matteo Costacurta, MD Peter MacCallum Cancer Centre University of Melbourne Australia “A genome-wide CRISPR screen identifies TOP2B as an acquired druggable vulnerability in the context of IMiD resistance” (Potential implications in multiple myeloma and lymphoma therapy)
READ MORE